ENZON PHARMACEUTICALS, INC.

Company

Viskase Holdings, Inc.

Filed

May 26, 2006

Accession Number

0000902664-06-001598

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →